Related Experiment Video
Updated: May 30, 2026
13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
[Ozone therapy in rheumatic diseases: a systematic review]
1Unidad de Investigación. Fundación Española de Reumatología. Madrid. España.
Reumatologia Clinica
|July 29, 2011
Summary
Ozone therapy for musculoskeletal conditions lacks strong evidence due to low-quality studies. Current data does not support a favorable risk/benefit ratio for ozone therapy in rheumatic diseases.
Area of Science:
- Orthopedics
- Rheumatology
- Pain Management
Context:
- Musculoskeletal diseases encompass a range of conditions affecting bones, joints, and muscles.
- Ozone therapy is an alternative treatment modality being explored for various medical conditions.
- Evidence for ozone therapy's efficacy in musculoskeletal disorders remains under investigation.
Purpose:
- To systematically review the existing literature on the efficacy of ozone therapy for musculoskeletal diseases.
- To evaluate the quality of studies assessing ozone therapy's effectiveness in conditions like lumbar disc herniation and Raynaud's syndrome.
Summary:
- A review of 6 studies (5 on lumbar disc herniation, 1 on Raynaud's syndrome) revealed significant limitations.
- Included studies often lacked random allocation, used subjective outcome measures, and had small sample sizes.
- Variability in ozone dosage and comparator groups, along with inadequate adverse event reporting, further compromised study quality.
Impact:
- The current evidence base for ozone therapy in musculoskeletal diseases is of poor quality.
- Insufficient data exists to establish an adequate risk/benefit profile for ozone therapy in rheumatic conditions.
- Further high-quality research is needed to determine the true therapeutic value and safety of ozone therapy.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation